• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肝硬化中消耗性凝血病的发病率]

[The incidence of consumption coagulopathy in liver cirrhosis].

作者信息

Moreno Abadía V, Bermúdez García J M, Maldonado Martín A, Rico Irles J

出版信息

An Med Interna. 1989 Sep;6(9):466-71.

PMID:2562720
Abstract

DIC in patients affected by cirrhosis, accompanied by portal hypertension and splenomegaly, has been suspected in the past. The main aim of this study is to ascertain the incidence of this phenomenon. We carried out coagulation and fibrinolytic tests in 113 cirrhotic patients and 20 healthy control persons. We found chronic consumption coagulopathy at analysis level in 28 cases (24.8%) with a decrease of fibrinogen, factor V, kallikrein, platelets, prothrombin complex activity, increase of PDF, partial thromboplastic time and euglobulin lysis. 25 cases had active cirrhosis, with ascites, variceal bleeding and/or hepatic encephalopathy; 3 were non-active cirrhosis. Only 7 patients had clinical DIC. We observed that coagulation disorders increased with more active cirrhosis.

摘要

肝硬化患者伴有门静脉高压和脾肿大,过去曾怀疑存在弥散性血管内凝血(DIC)。本研究的主要目的是确定这种现象的发生率。我们对113例肝硬化患者和20名健康对照者进行了凝血和纤溶试验。我们发现,在分析水平上,28例(24.8%)存在慢性消耗性凝血病,表现为纤维蛋白原、因子V、激肽释放酶、血小板、凝血酶原复合物活性降低,PDF、部分凝血活酶时间和优球蛋白溶解增加。25例为活动性肝硬化,伴有腹水、静脉曲张出血和/或肝性脑病;3例为非活动性肝硬化。只有7例患者有临床DIC。我们观察到,随着肝硬化活动性增加,凝血障碍也会加重。

相似文献

1
[The incidence of consumption coagulopathy in liver cirrhosis].[肝硬化中消耗性凝血病的发病率]
An Med Interna. 1989 Sep;6(9):466-71.
2
Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?肝硬化中的弥散性血管内凝血:事实还是虚构?
Am J Gastroenterol. 1999 Oct;94(10):2977-82. doi: 10.1111/j.1572-0241.1999.01446.x.
3
Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.肝硬化中的纤维蛋白肽A:反对弥散性血管内凝血对慢性肝病凝血病起主要作用的证据
J Lab Clin Med. 1993 Jan;121(1):83-90.
4
[Evaluation of several parameters of coagulation in liver cirrhosis: disseminated intravascular coagulation or pseudo-disseminated intravascular coagulation?].[肝硬化患者凝血相关参数的评估:弥散性血管内凝血还是假性弥散性血管内凝血?]
Minerva Med. 1988 Mar;79(3):193-8.
5
Incidence and clinical significance of elevated fibrin(ogen) degradation product and/or D-dimer levels in liver cirrhosis patients.肝硬化患者中纤维蛋白(原)降解产物和/或D-二聚体水平升高的发生率及临床意义
Ital J Gastroenterol. 1990 Apr;22(2):70-4.
6
High D-dimer levels: a possible index of risk of overt disseminated intravascular coagulation and/or digestive bleeding in advanced liver cirrhosis?高D-二聚体水平:晚期肝硬化患者明显弥散性血管内凝血和/或消化道出血风险的可能指标?
Recenti Prog Med. 1994 Apr;85(4):230-4.
7
[The therapeutic management of consumption coagulopathy in progressive liver cirrhosis: low-dosage heparin therapy (author's transl)].[进展性肝硬化消耗性凝血病的治疗处理:低剂量肝素疗法(作者译)]
Wien Klin Wochenschr. 1976 Aug 13;88(15):488-94.
8
Coagulation studies in patients with cirrhosis of liver: bleeders vs non-bleeders.肝硬化患者的凝血研究:出血者与非出血者
Indian J Pathol Microbiol. 1990 Oct;33(4):323-7.
9
[Coagulation tests in septic surgical patients].[脓毒症外科患者的凝血试验]
Acta Med Croatica. 2004;58(5):389-94.
10
[Intravascular coagulation in cirrhotic patients. 6 cases].[肝硬化患者的血管内凝血。6例]
Nouv Presse Med. 1975 Apr 26;4(17):1267-76.

引用本文的文献

1
Antifibrinolytic amino acids for upper gastrointestinal bleeding in people with acute or chronic liver disease.抗纤溶氨基酸用于急慢性肝病患者上消化道出血的治疗
Cochrane Database Syst Rev. 2015 Jun 9;2015(6):CD006007. doi: 10.1002/14651858.CD006007.pub4.